3 Year Absolute Returns
124.36% ↑
NAV (₹) on 16 Nov 2026
23.46
1 Day NAV Change
-0.14%
Risk Level
Very High Risk
Rating
-
HDFC Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by HDFC Asset Management Company Ltd.. Launched on 14 Sep 2023, investors can start with a ... Read more
AUM
₹ 3,665.74 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.77% |
| Hospitals & Medical Services | 26.71% |
| Treps/Reverse Repo | 1.77% |
| Medical Equipment & Accessories | 0.31% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Divis Laboratories Ltd. | 9.44% | ₹ 345.91 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 7.74% | ₹ 283.56 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd. | 6.66% | ₹ 244.03 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 5.19% | ₹ 190.25 | Hospitals & Medical Services |
| Alkem Laboratories Ltd. | 4.75% | ₹ 173.98 | Pharmaceuticals |
| Cipla Ltd. | 4.06% | ₹ 148.93 | Pharmaceuticals |
| Acutaas Chemicals Limited | 3.70% | ₹ 135.73 | Pharmaceuticals |
| Max Healthcare Institute Limited | 3.44% | ₹ 126.13 | Hospitals & Medical Services |
| Aster DM Quality Care Limited | 3.37% | ₹ 123.37 | Hospitals & Medical Services |
| Lupin Ltd. | 3.35% | ₹ 122.97 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 3.35% | ₹ 122.94 | Pharmaceuticals |
| Neuland Laboratories Limited | 2.96% | ₹ 108.38 | Pharmaceuticals |
| Shilpa Medicare Ltd | 2.92% | ₹ 107.10 | Pharmaceuticals |
| Anthem Biosciences Limited | 2.92% | ₹ 107.05 | Pharmaceuticals |
| Rubicon Research Limited | 2.69% | ₹ 98.78 | Pharmaceuticals |
| Global Health Limited | 2.52% | ₹ 92.33 | Hospitals & Medical Services |
| PARAS HEALTHCARE LIMITED | 2.34% | ₹ 85.72 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 1.96% | ₹ 71.92 | Pharmaceuticals |
| Ipca Laboratories Ltd. | 1.93% | ₹ 70.69 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 1.92% | ₹ 70.56 | Hospitals & Medical Services |
| Krishna Institute Of Medical Sciences Limited | 1.89% | ₹ 69.10 | Hospitals & Medical Services |
| Molbio Diagnostics Limited | 1.87% | ₹ 68.54 | Hospitals & Medical Services |
| Zydus Lifesciences Limited | 1.86% | ₹ 68.37 | Pharmaceuticals |
| TREPS - Tri-party Repo | 1.77% | ₹ 65.01 | Others |
| Sai Life Sciences Limited | 1.74% | ₹ 63.76 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 1.66% | ₹ 60.83 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 1.61% | ₹ 59.01 | Hospitals & Medical Services |
| Wockhardt Ltd. | 1.47% | ₹ 53.85 | Pharmaceuticals |
| SYMBIOTEC PHARMALAB LIMITED | 1.38% | ₹ 50.46 | Pharmaceuticals |
| Biocon Ltd. | 1.33% | ₹ 48.91 | Pharmaceuticals |
| Gland Pharma Ltd. | 1.05% | ₹ 38.57 | Pharmaceuticals |
| CORONA REMEDIES LIMITED | 1.02% | ₹ 37.26 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 0.90% | ₹ 32.81 | Hospitals & Medical Services |
| Entero Healthcare Solutions Limited | 0.89% | ₹ 32.61 | Pharmaceuticals |
| Eris Lifesciences Ltd | 0.86% | ₹ 31.37 | Pharmaceuticals |
| Jubilant Pharmova Limited | 0.80% | ₹ 29.34 | Pharmaceuticals |
| BAJAJ HEALTHCARE LIMITED | 0.48% | ₹ 17.43 | Pharmaceuticals |
| Novartis India Limited | 0.46% | ₹ 17.03 | Pharmaceuticals |
| Laxmi Dental Limited | 0.31% | ₹ 11.44 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 31.69% | 30.32% | 20.78% | 30.91% |
| Category returns | 7.37% | 5.10% | 9.83% | 22.69% |
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
|
HDFC Silver ETF
ETF
Regular
|
₹161.78 | 5.37% | 123.83% | 0.00% | ₹6,755 | 0.50% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.01 | 16.97% | 122.46% | 0.00% | ₹11,131 | 1.79% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.01 | 16.97% | 122.46% | 0.00% | ₹11,131 | 1.79% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.01 | 16.97% | 122.46% | 0.00% | ₹11,131 | 1.79% |
Very High
|
|
HDFC Silver ETF Fund of Fund - Direct Plan
Fund of Funds
Direct
|
₹27.69 | 4.17% | 121.69% | 0.00% | ₹3,788 | 0.21% |
Very High
|
What is the current NAV of HDFC Pharma and Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of HDFC Pharma and Healthcare Fund - Direct Plan Growth?
What are the historical returns of HDFC Pharma and Healthcare Fund - Direct Plan Growth?
What is the risk level of HDFC Pharma and Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for HDFC Pharma and Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article